Eton Pharmaceuticals, Inc.
ETON · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $344,921 | $112,325 | $70,911 | $108,138 |
| - Cash | $14,936 | $21,388 | $16,305 | $14,406 |
| + Debt | $29,918 | $5,402 | $6,524 | $6,695 |
| Enterprise Value | $359,903 | $96,339 | $61,130 | $100,427 |
| Revenue | $39,011 | $31,642 | $21,251 | $21,832 |
| % Growth | 23.3% | 48.9% | -2.7% | – |
| Gross Profit | $23,411 | $21,061 | $14,318 | $19,209 |
| % Margin | 60% | 66.6% | 67.4% | 88% |
| EBITDA | -$1,451 | -$291 | -$6,486 | -$1,033 |
| % Margin | -3.7% | -0.9% | -30.5% | -4.7% |
| Net Income | -$3,823 | -$936 | -$9,021 | -$1,955 |
| % Margin | -9.8% | -3% | -42.4% | -9% |
| EPS Diluted | -0.15 | -0.037 | -0.36 | -0.078 |
| % Growth | -311% | 89.9% | -363.9% | – |
| Operating Cash Flow | $969 | $6,815 | $4,821 | -$4,721 |
| Capital Expenditures | -$26 | -$775 | -$2,788 | -$3,259 |
| Free Cash Flow | $943 | $6,040 | $2,033 | -$7,980 |